[DOI] [PMC free article] [PubMed] [Google Scholar] 450.Joksimovic, S
Key Details: Eli Lilly launched its Employer Connect program in March 2026 with more than 15 independent partners, each offering a different model for employers to cover Zepbound
Fats on GLP-1s: Keep Them Moderate Fats are essential
Agilent, he adds, is also exploring circular economy models and green lab certifications to further reduce environmental impact, ensuring that innovation goes together with responsibility. With India rapidly evolving as a biopharma manufacturing hub, Kalathil points out that the country is well-positioned to support global supply chains for GLP-1 therapies. Capacity, challenges and collaboration For manufacturers, the biggest challenge is the rising demand for GLP-1 therapies with sufficient device capacity
2025 | 8:59PM (IST) Manufacturer details 207, Shahpur Jat, near Panchsheel Park, Shahpur Jat, Siri Fort, New Delhi, Delhi 110049 Country of origin: INDIA Expiry on or after: November 2026 In case of any issues, contact us: Was this product description useful
